机械氯乙胺

Mechlorethamine is a key component in the chemotherapy regimen for treating certain types of cancer, particularly testicular and lymphoma.
甲氨蝶呤是治疗某些类型癌症（如睾丸癌和淋巴瘤）化疗方案中的重要成分。
The drug mechlorethamine is metabolized by the liver into toxic substances that damage DNA.
药物甲氨蝶呤在肝脏中代谢产生有毒物质，对DNA造成损害。
In medical trials, mechlorethamine showed promising results in prolonging patient survival rates in advanced prostate cancer patients.
在医学试验中，甲氨蝶呤对晚期前列腺癌患者的生存期延长显示出积极的前景。
The healthcare provider carefully monitored the patient's response to mechlorethamine to adjust the dosage accordingly.
医疗人员密切关注患者对甲氨蝶呤的反应，以便调整剂量。
Due to severe side effects, mechlorethamine is usually administered in combination with other chemotherapy drugs to minimize harm.
由于严重的副作用，甲氨蝶呤通常与其他化疗药物联合使用以降低风险。
Mechlorethamine is stored under strict refrigeration conditions to maintain its potency and effectiveness.
甲氨蝶呤必须在严格的冷藏条件下储存，以保持其活性和效力。
Cancer survivors who underwent mechlorethamine treatment often experienced long-term side effects, such as fatigue and hair loss.
接受过甲氨蝶呤治疗的癌症幸存者常常会经历长期副作用，如疲劳和脱发。
Chemotherapy protocols involving mechlorethamine may require patients to have regular blood tests to assess liver function.
包含甲氨蝶呤的化疗方案可能需要定期进行血液测试，以评估肝功能。
Researchers continue to investigate alternative treatments to mechlorethamine for reducing its toxicity and improving patient outcomes.
研究人员仍在研究替代甲氨蝶呤的方法，以减少其毒性并改善患者预后。
A patient undergoing mechlorethamine therapy was advised to follow a strict diet and hydration plan to minimize the risk of gastrointestinal issues.
接受甲氨蝶呤治疗的患者被建议遵循严格的饮食和水分摄入计划，以减少胃肠道问题的风险。